| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 2,000 | $227.71 | $455,420.00 | -2.6% | +10.4% | +14.1% | |
| Mar 5, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 472 | $25.29 | $11,934.52 | -0.3% | +12.1% | +49.2% | |
| Mar 5, 2025 | PEN Penumbra Inc | Elsesser Adam62 | CEO And President | Sell | 61,600 | $283.59 | $17,468,917.42 | -19.8% | -10.1% | +18.9% | |
| Mar 5, 2025 | OFIX Orthofix Medical Inc. | Calafiore Massimo61 | President &CEO | Buy | 9,914 | $17.43 | $172,801.02 | +4.7% | -36.2% | -27.3% | |
| Mar 5, 2025 | ATRC Atricure, Inc. | Prange Karen | Director | Sell | 6,100 | $38.12 | $232,532.00 | -25.5% | -8.2% | -20.0% | |
| Mar 5, 2025 | MMSI Merit Medical Systems Inc | Parra Raul Jr.61 | CFO And Treasurer | Sell | 5,361 | $103.58 | $555,292.38 | -18.1% | -9.8% | -29.9% | |
| Mar 5, 2025 | MMSI Merit Medical Systems Inc | Lampropoulos Fred P66 | President And CEO | Sell | 34,320 | $103.85 | $3,564,069.23 | -1.5% | -9.8% | -29.9% | |
| Mar 5, 2025 | ZBH Zimmer Biomet Holdings, Inc. | Winkler Lori66 | SVP And CHRO | Sell | 1,443 | $104.40 | $150,649.20 | -14.1% | -12.3% | -10.8% | |
| Mar 5, 2025 | ISRG Intuitive Surgical Inc | Rosa David J.54 | President | Sell | 16,509 | $557.52 | $9,204,142.82 | -3.5% | -2.8% | -12.6% | |
| Mar 5, 2025 | AORT Artivion, Inc. | Semedo Anthony B.50 | Director | Buy | 2,100 | $25.31 | $53,140.50 | +6.1% | +12.1% | +49.2% | |
| Mar 5, 2025 | MMSI Merit Medical Systems Inc | Lloyd Brian G.60 | Chief Legal Officer, Secretary | Sell | 30,000 | $102.90 | $3,087,000.00 | -43.5% | -9.8% | -29.9% | |
| Mar 4, 2025 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 377 | $4.48 | $1,688.96 | - | -24.7% | -73.7% | |
| Mar 4, 2025 | STAA Staar Surgical Co | Broadwood Partners, L.P.60 | 10% Owner | Buy | 27,953 | $17.24 | $481,849.07 | - | -6.0% | +8.2% | |
| Mar 4, 2025 | LMAT Lemaitre Vascular Inc | Jasinski Lawrence J62 | Director | Sell | 3,142 | $92.00 | $289,064.00 | -54.7% | -11.1% | +17.7% | |
| Mar 4, 2025 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Officer | Buy | 60,000 | $8.73 | $524,064.00 | +0.9% | -35.1% | -83.4% | |
| Mar 4, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 599 | $69.99 | $41,924.01 | -2.3% | -6.3% | +41.8% | |
| Mar 4, 2025 | STIM Neuronetics, Inc. | Furlong Stephen74 | EVP, CFO And Treasurer | Sell | 1,867 | $4.48 | $8,364.16 | -0.3% | -24.7% | -73.7% | |
| Mar 4, 2025 | CERS Cerus Corp | Greenman William Mariner70 | President And CEO | Sell | 23,023 | $1.55 | $35,651.12 | -0.7% | -16.5% | +41.1% | |
| Mar 4, 2025 | BSX Boston Scientific Corp | Woodworth Emily53 | SVP, Global Controller And CAO | Sell | 7,631 | $104.95 | $800,896.51 | -85.0% | +0.5% | -30.3% | |
| Mar 4, 2025 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 177,967 | $24.26 | $4,317,541.94 | -70.3% | -7.5% | +17.8% | |
| Mar 4, 2025 | CERS Cerus Corp | Jayaraman Vivek K67 | Chief Operating Officer | Sell | 10,780 | $1.55 | $16,692.83 | -1.2% | -16.5% | +41.1% | |
| Mar 4, 2025 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 202,968 | $23.51 | $4,772,513.20 | -69.7% | -7.5% | +17.8% | |
| Mar 4, 2025 | CERS Cerus Corp | Green Kevin Dennis71 | Chief Financial Officer | Sell | 69,042 | $1.57 | $108,658.43 | -6.2% | -16.5% | +41.1% | |
| Mar 4, 2025 | WRBY Warby Parker Inc. | Miller Steven Clive62 | Chief Financial Officer | Sell | 11,684 | $23.52 | $274,807.68 | -5.4% | -7.5% | +17.8% | |
| Mar 4, 2025 | BLFS Biolife Solutions Inc | Werner Sean60 | Chief Technology Officer | Sell | 224 | $24.90 | $5,577.20 | -2.2% | -16.7% | -16.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.